JP2016538262A - 抗菌剤を含む医薬品組成物 - Google Patents

抗菌剤を含む医薬品組成物 Download PDF

Info

Publication number
JP2016538262A
JP2016538262A JP2016525559A JP2016525559A JP2016538262A JP 2016538262 A JP2016538262 A JP 2016538262A JP 2016525559 A JP2016525559 A JP 2016525559A JP 2016525559 A JP2016525559 A JP 2016525559A JP 2016538262 A JP2016538262 A JP 2016538262A
Authority
JP
Japan
Prior art keywords
pharmaceutically acceptable
acceptable derivative
compound
formula
imipenem
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016525559A
Other languages
English (en)
Japanese (ja)
Inventor
サチン バグワット
サチン バグワット
マヘシュ ヴィタルバイ パテル
マヘシュ ヴィタルバイ パテル
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wockhardt Ltd
Original Assignee
Wockhardt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wockhardt Ltd filed Critical Wockhardt Ltd
Publication of JP2016538262A publication Critical patent/JP2016538262A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Hydrogenated Pyridines (AREA)
JP2016525559A 2013-10-22 2014-10-22 抗菌剤を含む医薬品組成物 Pending JP2016538262A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN3308/MUM/2013 2013-10-22
IN3308MU2013 IN2013MU03308A (enrdf_load_stackoverflow) 2013-10-22 2014-10-22
PCT/IB2014/065521 WO2015059642A1 (en) 2013-10-22 2014-10-22 Pharmaceutical compositions comprising antibacterial agents

Publications (1)

Publication Number Publication Date
JP2016538262A true JP2016538262A (ja) 2016-12-08

Family

ID=52003011

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016525559A Pending JP2016538262A (ja) 2013-10-22 2014-10-22 抗菌剤を含む医薬品組成物

Country Status (10)

Country Link
US (1) US9789097B2 (enrdf_load_stackoverflow)
EP (1) EP3060208B1 (enrdf_load_stackoverflow)
JP (1) JP2016538262A (enrdf_load_stackoverflow)
CN (1) CN106132411A (enrdf_load_stackoverflow)
AU (1) AU2014338611A1 (enrdf_load_stackoverflow)
CA (1) CA2928358A1 (enrdf_load_stackoverflow)
IN (1) IN2013MU03308A (enrdf_load_stackoverflow)
MX (1) MX2016005160A (enrdf_load_stackoverflow)
RU (1) RU2016115374A (enrdf_load_stackoverflow)
WO (1) WO2015059642A1 (enrdf_load_stackoverflow)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018193368A1 (en) * 2017-04-18 2018-10-25 Wockhardt Limited Antibacterial compositions
US11905286B2 (en) 2018-08-09 2024-02-20 Antabio Sas Diazabicyclooctanones as inhibitors of serine beta-lactamases
SMT202300354T1 (it) 2018-08-09 2023-11-13 Antabio Sas Diazabicicloottanoni come inibitori delle beta-lattamasi a serina

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013038330A1 (en) * 2011-09-13 2013-03-21 Wockhardt Limited Nitrogen containing compounds and their use

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101713472B1 (ko) * 2005-09-22 2017-03-07 메이지 세이카 파루마 가부시키가이샤 메탈로-β-락타마제 저해제

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013038330A1 (en) * 2011-09-13 2013-03-21 Wockhardt Limited Nitrogen containing compounds and their use

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, vol. 63, no. 4, JPN5016010997, 2009, pages 426 - 433, ISSN: 0003977093 *
PHARMACOTHERAPY, vol. 30, no. 4, JPN5016010995, 2010, pages 354 - 360, ISSN: 0003977090 *
日薬理誌, vol. 107, JPN6018024982, 1996, pages 53 - 66, ISSN: 0003977092 *
第十四改正日本薬局方解説書, JPN6018024981, 2001, pages 273 - 275, ISSN: 0003977091 *

Also Published As

Publication number Publication date
RU2016115374A3 (enrdf_load_stackoverflow) 2018-08-15
MX2016005160A (es) 2016-10-05
IN2013MU03308A (enrdf_load_stackoverflow) 2015-07-17
WO2015059642A1 (en) 2015-04-30
EP3060208B1 (en) 2018-09-19
AU2014338611A1 (en) 2016-05-12
US9789097B2 (en) 2017-10-17
CN106132411A (zh) 2016-11-16
RU2016115374A (ru) 2017-11-28
US20160303094A1 (en) 2016-10-20
CA2928358A1 (en) 2015-04-30
EP3060208A1 (en) 2016-08-31

Similar Documents

Publication Publication Date Title
JP6886996B2 (ja) 抗菌剤を含む医薬組成物
JP6525999B2 (ja) 抗菌性組成物
JP2016538262A (ja) 抗菌剤を含む医薬品組成物
JP2017506240A (ja) 抗菌剤を含む医薬組成物
JP2017507162A (ja) 抗菌薬を含む医薬組成物
JP2016535038A (ja) 抗菌剤を含む医薬品組成物
JP2017511359A (ja) 抗菌薬を含む医薬組成物
AU2014338612A1 (en) Pharmaceutical compositions comprising antibacterial agents
JP2017508769A (ja) セフェピムまたはスルバクタムを含む医薬組成物
WO2015159263A1 (en) Pharmaceutical compositions comprising antibacterial agents
KR20160072253A (ko) 항균제를 포함하는 제약학적 조성물
KR20160072262A (ko) 항균제를 포함하는 제약학적 조성물

Legal Events

Date Code Title Description
RD03 Notification of appointment of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7423

Effective date: 20170323

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20170327

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20171020

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20180702

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20190218